| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.8M | -58.2% |
| Cost of Revenue | $2.1M | -25.1% |
| R&D Expense | $52.6M | +56.7% |
| SG&A Expense | $22.0M | -1.0% |
| Operating Income | -$76.4M | +46.2% |
| Pre-tax Income | -$64.9M | +50.8% |
| Net Income | -$64.9M | +50.8% |
| EPS (Basic) | -$0.53 | +69.0% |
| EPS (Diluted) | -$0.53 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.0M | -18.8% |
| Current Assets | $96.3M | -23.5% |
| Total Assets | $160.5M | -27.2% |
| Current Liabilities | $28.6M | -9.3% |
| Total Liabilities | $57.4M | -11.4% |
| Stockholders' Equity | $103.1M | -33.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$47.1M | -134.7% |
| Capital Expenditures | $111K | -8.3% |
| Investing Cash Flow | $48.4M | +169.3% |
| Financing Cash Flow | -$5.9M | -107.9% |
| Free Cash Flow | -$47.2M | -133.8% |
| +69.0% |